GoHealth price target lowered to $13 from $20 at RBC Capital

RBC Capital lowered the firm’s price target on GoHealth to $13 from $20 and keeps a Sector Perform rating on the shares. The company’s Q4 results came in well below expectations driven by lower submissions, and its volumes were impacted by fewer plan switchers as a result of limited Medicare Advantage product differentiation, the analyst tells investors in a research note. GoHealth’s cash flow from operations is also expected to be flat to slightly up as the company continues to transition to its Encompass model, the firm added.